Catalent Management
Management criteria checks 2/4
Catalent's CEO is Alessandro Maselli, appointed in Jul 2022, has a tenure of 1.83 years. total yearly compensation is $6.58M, comprised of 14% salary and 86% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth $1.89M. The average tenure of the management team and the board of directors is 1.5 years and 8.8 years respectively.
Key information
Alessandro Maselli
Chief executive officer
US$6.6m
Total compensation
| CEO salary percentage | 14.0% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | 1.5yrs |
| Board average tenure | 8.8yrs |
Recent management updates
Recent updates
Catalent - Novo Holdings Merger: Attractive Spread
Feb 07Catalent: Debt Remains An Overhang
Dec 13Catalent Remains Overvalued
Oct 04Calculating The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)
Aug 14
Catalent: Myriad Issues To Fix
Jul 31Catalent (NYSE:CTLT) Has A Somewhat Strained Balance Sheet
May 05A Look At The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)
Mar 27Why did Catalent stock soar today? Potential takeover by Danaher
Feb 06We Think Catalent (NYSE:CTLT) Is Taking Some Risk With Its Debt
Feb 01Catalent to make Sarepta Therapeutics' muscle wasting gene therapy under supply deal
Jan 05An Intrinsic Calculation For Catalent, Inc. (NYSE:CTLT) Suggests It's 27% Undervalued
Dec 27Humanigen to pay Catalent Pharma $12M to settle supply agreement dispute
Dec 22Catalent falls after new short call from Glasshouse Research
Dec 08Catalent Q1 2023 Earnings Preview
Oct 31These 4 Measures Indicate That Catalent (NYSE:CTLT) Is Using Debt Extensively
Oct 26Catalent: Charting A Post-Covid Future
Oct 19Calculating The Fair Value Of Catalent, Inc. (NYSE:CTLT)
Sep 16Catalent Non-GAAP EPS of $1.19 beats by $0.04, revenue of $1.31B misses by $20M
Aug 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$1b |
| Sep 30 2023 | n/a | n/a | -US$1b |
| Jun 30 2023 | US$7m | US$925k | -US$256m |
| Mar 31 2023 | n/a | n/a | US$21m |
| Dec 31 2022 | n/a | n/a | US$389m |
| Sep 30 2022 | n/a | n/a | US$399m |
| Jun 30 2022 | US$3m | US$654k | US$483m |
| Mar 31 2022 | n/a | n/a | US$485m |
| Dec 31 2021 | n/a | n/a | US$561m |
| Sep 30 2021 | n/a | n/a | US$544m |
| Jun 30 2021 | US$5m | US$640k | US$529m |
| Mar 31 2021 | n/a | n/a | US$494m |
| Dec 31 2020 | n/a | n/a | US$289m |
| Sep 30 2020 | n/a | n/a | US$250m |
| Jun 30 2020 | US$3m | US$483k | US$173m |
| Mar 31 2020 | n/a | n/a | US$104m |
| Dec 31 2019 | n/a | n/a | US$124m |
| Sep 30 2019 | n/a | n/a | US$138m |
| Jun 30 2019 | US$2m | US$450k | US$132m |
Compensation vs Market: Alessandro's total compensation ($USD6.58M) is below average for companies of similar size in the US market ($USD13.53M).
Compensation vs Earnings: Alessandro's compensation has increased whilst the company is unprofitable.
CEO
Alessandro Maselli (51 yo)
1.8yrs
Tenure
US$6,583,672
Compensation
Mr. Alessandro Maselli has been President of Catalent Pharma Solutions, Inc. from February 2019 and serves as its Director since July 01, 2022 and is its Chief Executive Officer and was its Chief Operation...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.8yrs | US$6.58m | 0.019% $ 1.9m | |
| Group President of Pharma & Consumer Health Segment | 5.3yrs | US$3.80m | 0.030% $ 3.1m | |
| President | less than a year | US$972.31k | 0.0045% $ 456.9k | |
| Executive Chairman of the Board | 6.3yrs | US$314.97k | 0.024% $ 2.4m | |
| Senior VP & CFO | less than a year | no data | no data | |
| VP & Chief Accounting Officer | less than a year | no data | no data | |
| Senior VP & Chief Information Officer | 4yrs | no data | 0.0060% $ 608.5k | |
| Vice President of Investor Relations | 4.3yrs | no data | no data | |
| Senior VP | 1.3yrs | no data | no data | |
| Senior Vice President of Strategy & Corporate Development | 4.6yrs | no data | 0.013% $ 1.3m | |
| Senior VP & Chief Human Resources Officer | less than a year | no data | no data | |
| Senior Vice President of Quality & Regulatory Affairs | 7yrs | no data | 0.016% $ 1.6m |
1.5yrs
Average Tenure
51yo
Average Age
Experienced Management: CTLT's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.8yrs | US$6.58m | 0.019% $ 1.9m | |
| Executive Chairman of the Board | 6.3yrs | US$314.97k | 0.024% $ 2.4m | |
| Independent Director | 8.5yrs | US$384.95k | 0.026% $ 2.6m | |
| Independent Director | 9.8yrs | US$384.95k | 0.0061% $ 618.6k | |
| Member of Advisory Board | 8.8yrs | no data | no data | |
| Independent Lead Director | 9.8yrs | US$395.11k | 0.015% $ 1.6m | |
| Independent Director | 9.1yrs | US$387.61k | 0.00077% $ 77.8k | |
| Independent Director | 8.8yrs | US$426.36k | 0.018% $ 1.8m | |
| Member of Advisory Board | 9.1yrs | no data | no data | |
| Member of Advisory Board | 8.8yrs | no data | no data | |
| Member of Scientfic & Advisory Board | 8.8yrs | no data | no data | |
| Member of Advisory Board | 8.8yrs | no data | no data |
8.8yrs
Average Tenure
66yo
Average Age
Experienced Board: CTLT's board of directors are considered experienced (8.8 years average tenure).